April 22, 2019

Background

swapnil hiremath

The SGLT2i Crescendo with CREDENCE

This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.

April 8, 2019

Background

swapnil hiremath

How can we ASCEND from the depths of ...

This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.

cancer

joel topf

November 26, 2018

Background

Sirolimus as a Savior for Skin Cancer?

joel topf

November 26, 2018

Background

Join us to discuss this extension of the TUMORAPA trial - in a joint session with the #DermJC. Should kidney transplant recipients with squamous cell cancer be switched to sirolimus?